Savara
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The firm's lead program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
CEOMatthew Pauls
CEOMatthew Pauls
Employees22
Employees22
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1995
Founded1995
Employees22
Employees22
SVRA Key Statistics
Market cap177.91M
Market cap177.91M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume117.60K
Average volume117.60K
High today$1.56
High today$1.56
Low today$1.44
Low today$1.44
Open price$1.46
Open price$1.46
Volume69.84K
Volume69.84K
52 Week high$1.91
52 Week high$1.91
52 Week low$1.02
52 Week low$1.02
SVRA Earnings
-$0.23
-$0.15
-$0.08
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Nov 11, After Hours
ActualExpected Nov 11, After Hours